NCT01920750View on ClinicalTrials.gov

Leprosy Skin Test Antigens Phase 1

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 1989

Primary Completion Date

February 28, 1999

Study Completion Date

February 28, 1999

Conditions
Leprosy
Interventions
BIOLOGICAL

MLCwA

Antigen MLSA-LAM is a pellet extracted 3x followed by removal of SDS by column chromatography. Contains many of the same proteins

BIOLOGICAL

MLSA-LAM

Antigen MLSA-LAM is derived from M. leprae extract following sonication and centrifugation, leaving the cytosol (MLSA). Contains soluble protein antigens of M. leprae

OTHER

Mock Antigen

Physiological saline

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH